Paul Badawi's Insider Trades & SAST Disclosures
Paul Badawi's most recent trade in Sight Sciences Inc was a trade of 24,174 Common Stock done at an average price of $2.3 . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Paul Badawi.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.30 per share. | 01 Apr 2025 | 24,174 | 6,010,580 | - | 2.3 | 55,673 | Common Stock |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 358,423 | 6,034,754 | - | 0 | Common Stock | |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.92 per share. | 16 Jan 2025 | 24,819 | 5,676,331 | - | 2.9 | 72,571 | Common Stock |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.58 per share. | 07 Jan 2025 | 12,047 | 5,701,150 | - | 3.6 | 43,128 | Common Stock |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.60 per share. | 02 Jan 2025 | 12,236 | 5,713,197 | - | 3.6 | 44,013 | Common Stock |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.99 per share. | 02 Oct 2024 | 12,727 | 5,725,433 | - | 6.0 | 76,184 | Common Stock |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.42 per share. | 01 Jul 2024 | 12,569 | 5,738,160 | - | 6.4 | 80,655 | Common Stock |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.08 per share. | 03 Apr 2024 | 12,571 | 5,750,729 | - | 5.1 | 63,848 | Common Stock |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 390,187 | 5,763,300 | - | 0 | Common Stock | |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.16 per share. | 17 Jan 2024 | 15,917 | 5,319,539 | - | 5.2 | 82,195 | Common Stock |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.17 per share. | 03 Jan 2024 | 8,975 | 5,335,456 | - | 5.2 | 46,419 | Common Stock |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 225,700 | 225,700 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 176,600 | 5,278,481 | - | 0 | Common Stock | |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 87,800 | 5,286,732 | - | 0 | Common Stock | |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.21 per share. | 01 Jan 2023 | 8,251 | 5,278,481 | - | 12.2 | 100,745 | Common Stock |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 351,300 | 351,300 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 87,800 | 87,800 | - | - | Restricted Stock Units | |
| Sight Sciences Inc | Paul Badawi | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2021 | 58,753 | 58,753 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges